This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure is particularly valuable in the development of central nervous system (CNS) drugs, including antidepressants and antipsychotics, due to its ability to interact with neurotransmitter systems. Additionally, it serves as a building block in the creation of compounds targeting neurological disorders, leveraging its fluorinated naphthalene core for enhanced binding affinity and metabolic stability. Researchers also explore its potential in designing novel therapeutic agents for conditions like Parkinson’s disease and anxiety disorders.